“2030 vitrectomy devices market value to reach USD 1.87 billion”
The global vitrectomy devices market size was valued at USD 1.28 billion in 2023 and is expected to expand at a CAGR of 5.3% from 2024 to 2030. The increasing prevalence of retinal diseases and their root causes are expected to drive growth for the market in the forecast period. Diabetes has been affecting eye health by damaging the blood vessels in the retina, resulting in vision impairment. Increasing numbers of new cases of diabetes are also anticipated to influence the market in the coming years.
Vitrectomy devices are essential tools used in eye surgery to address various conditions. Surgeons use them to remove vitreous gel during vitrectomy procedures. Vitrectomy is employed for conditions like retinal detachment, macular hole, and diabetic retinopathy. The availability of more compact and portable devices, adding the ease of use factor of surgical procedures, is helping the market generate greater demand.
Advancements in vitrectomy techniques, such as smaller gauge instruments, enhanced vitrectomy machine fluidics, improved wide-angle viewing systems, and specially designed microsurgical instruments, are also expected to grow this market significantly during the forecast period. Innovation backed by intensive research and development is increasingly adopted into product development by key companies, which has also fueled the industry's growth in recent years.
“The vitrectomy packs segment is expected to grow at a CAGR of 6.1%”
The vitrectomy machines segment dominated the market and held the largest revenue share of 37.0% in 2023. The segment’s growth is driven by the emergence of next-generation machines equipped with enhanced features, including improved fluidics, higher cut rates, and intraocular pressure management.
The vitrectomy packs segment is expected to grow fastest from 2024 to 2030. The growing adoption of vitrectomy packs across diverse indications, including vitreous removal, epiretinal membrane removal, collective retinal surgeries, and posterior vitreous detachment, contributes to this trend. Furthermore, the added advantages of portability, optical magnification, and enhanced sensitivity associated with vitrectomy packs are anticipated to drive market growth.
“The retinal detachment segment to witness a rapid growth rate of 6.0%”
The macular hole segment dominated the market and is expected to maintain its dominance over the forecast period. A macular hole is an ailment that affects the retina's center, i.e., the macula. When a macular hole impacts vision, vitrectomy is one of the most common solutions, as it directly addresses the underlying issue. While some macular holes may heal spontaneously, many necessitate vitrectomy surgery to enhance vision. Factors such as high myopia, eye injuries, and retinal detachment can also contribute to macular hole formation. Consequently, the rising prevalence of these conditions is anticipated to drive growth in this segment.
The retinal detachment segment is expected to experience the fastest growth during the forecast period 2024 to 2030. Retinal detachment predominantly occurs in individuals with high myopia and can lead to permanent loss of vision. Therefore, the rising prevalence of high myopia, resulting in a greater number of vitrectomy surgeries, is projected to positively influence this segment.
“The ambulatory surgical centers segment to witness fastest growth of 5.8%”
The hospital segment dominated the market and held the largest revenue share in 2023. It is attributed to the increased number of vitrectomy surgeries in these facilities. Numerous hospitals now provide ophthalmic care, including vitrectomy procedures. The presence of necessary infrastructure, trained professionals, advanced equipment empowered with uninterrupted energy supply, and availability of other practitioners in case of emergencies add benefits to the setting. This has been developing lucrative growth for this segment in recent years.
The Ambulatory surgical centers (ASCs) segment is projected to grow over the forecast period. The increasing prevalence of ocular disorders is fueling growth in this segment. Patients and professionals have preferred ambulatory surgeries over the last few years. According to The Ambulatory Surgery Center Association (ASCA), nearly 6200 Medicare-certified ambulatory surgical centers were operating across the U.S. in 2022, with 468 and 458 in Florida and Texas, respectively. Regarding a single specialty, ophthalmology had 755 ASCs operating in the country. Patients are inclined towards ASCs, as these facilities are known for providing multiple benefits, including cost savings.
“Mexico to witness fastest market growth of CAGR 6.5%”
North America vitrectomy devices market dominated the global industry in 2023 with a share of 35.9%. The increasing incidence of ophthalmic ailments like diabetic retinopathy, macular holes, and retinal detachment is driving market growth in the region. Furthermore, key market players in the region fuel this trend. These companies secure U.S. FDA clearance for their products, ensuring their competitive position and compliance in the market.
The vitrectomy devices market in the U.S. is expected to experience a significant CAGR from 2024 to 2030. This market is primarily driven by the crucial increase in the country's geriatric population. According to the United States Census Bureau, 1 in 6 individuals in the U.S. were 65 and older during the 2020 census. It has a vital role in increasing demand for the vitrectomy devices market. According to the U.S. Centers for Disease Control and Prevention, the leading cause behind blindness in American adults was identified as Diabetic retinopathy (DR).
The Asia Pacific vitrectomy devices market is expected to grow fastest during the forecast period. Large geriatric populations in countries such as China and India, the growing reach of enhanced healthcare infrastructure and facilities, and the substantial number of patients seeking ophthalmic care are likely to boost the demand for vitrectomy devices. An increasing number of healthcare initiatives by government and non-profit organizations in the region are also expected to contribute to the growth of this industry.
India vitrectomy devices market is a key country-based market in the regional industry. This is attributed to the country's unceasing growth in retinal detachment and diabetic retinopathy cases. According to the World Health Organization (WHO), approximately 77 million adults over the age of 18 are estimated to suffer from diabetes (type 2) in India.
Europe vitrectomy devices market is poised for substantial growth during the forecast period. This can be attributed to several factors, including the high prevalence of eye diseases, surging demand for technologically advanced products, and increased research and development (R&D) investments in innovative solutions. The presence of key companies in the region also contributes to the growth. Some prominent regional organizations are Carl Zeiss, Alcon, NIDEK, Bausch Health, and Danaher.
The vitrectomy market in Germany is expected to dominate the regional industry in the upcoming years. This is primarily due to growing awareness of diseases such as diabetic retinopathy, the availability and easy accessibility of vitrectomy devices, the presence of key companies, and enhanced healthcare infrastructure coupled with expert professionals.
Some of the key companies in the vitrectomy devices market are Alcon Inc., Bausch + Lomb., Carl Zeiss Meditec AG, BVI and Johnson & Johnson Vision Care, Inc. Owing to the rising level of competition and increasing demand, companies in the industry are experimenting with strategies such as significant investment in research and development, forming collaborations and partnerships, fostering innovation, and introducing new products.
Bausch + Lomb offers a variety of eye care products, such as contact lenses, lens care products, pharmaceuticals, and intraocular lenses. The company also offers Vitesse, a hypersonic vitrectomy system equipped with advanced technology for vitreous removal.
Alcon is a global company in the eye care industry that engages in complementary businesses in surgical and vision care markets across several countries. The company is applauded across the industry for its CONSTELLATION vision system.
The following are the leading companies in the vitrectomy devices market. These companies collectively hold the largest market share and dictate industry trends.
In April 2024, Carl Zeiss Meditec AG, a prominent market participant in the ophthalmic medical devices industry, acquired the Dutch Ophthalmic Research Center (D.O.R.C.). This strategic move is expected to enhance Zeiss's digital workflow solutions portfolio in the coming years.
Report Attribute |
Details |
Market size value in 2024 |
USD 1.37 billion |
Revenue forecast in 2030 |
USD 1.87 billion |
Growth rate |
CAGR of 5.3% from 2024 to 2030 |
The base year for estimation |
2023 |
Historical data |
2018 - 2022 |
Forecast period |
2024 - 2030 |
Report updated |
August 2024 |
Quantitative units |
Revenue in USD million and CAGR from 2018 to 2030 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Product, application, end use, and region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East and Africa |
Country scope |
U.S.; Canada; UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; Japan; China; India; Australia; Thailand; South Korea; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait |
Key companies profiled |
Alcon Inc.; Bausch + Lomb; BVI; NIDEK CO., LTD.; Johnson & Johnson Vision Care, Inc.; Blink Medical; Topcon Corporation; Hoya Surgical Optics; Carl Zeiss Meditec AG |
Customization scope |
Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional, and segment scope |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global vitrectomy devices market based on product, application, end use, and region:
Product Outlook (Revenue, USD Million, 2018 - 2030)
Vitrectomy machines
Vitrectomy packs
Photocoagulation lasers
Illumination devices
Application Outlook (Revenue, USD Million, 2018 - 2030)
Diabetic retinopathy
Retinal detachment
Macular hole
Vitreous hemorrhage
Others
End Use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Ophthalmic clinics
Ambulatory surgical centers
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Thailand
South Korea
Australia
Latin America
Brazil
Argentina
Middle East and Africa
South Africa
Saudi Arabia
UAE
Kuwait
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."